Wiessner C - Search Results

1

The second-generation active Aβ immunotherapy CAD106 reduces amyloid accumulation in APP transgenic mice while minimizing potential side effects.

Wiessner C, Wiederhold KH, Tissot AC, Frey P, Danner S, Jacobson LH, Jennings GT, Lüönd R, Ortmann R, Reichwald J, Zurini M, Mir A, Bachmann MF, Staufenbiel M. Wiessner C, et al. J Neurosci. 2011 Jun 22;31(25):9323-31. doi: 10.1523/JNEUROSCI.0293-11.2011. J Neurosci. 2011. PMID: 21697382 Free PMC article.

2

Increased exploratory activity of APP23 mice in a novel environment is reversed by siRNA.

Senechal Y, Prut L, Kelly PH, Staufenbiel M, Natt F, Hoyer D, Wiessner C, Dev KK. Senechal Y, et al. Among authors: wiessner c. Brain Res. 2008 Dec 3;1243:124-33. doi: 10.1016/j.brainres.2008.09.024. Epub 2008 Sep 18. Brain Res. 2008. PMID: 18823960

3

Thrombolysis induces cerebral hemorrhage in a mouse model of cerebral amyloid angiopathy.

Winkler DT, Biedermann L, Tolnay M, Allegrini PR, Staufenbiel M, Wiessner C, Jucker M. Winkler DT, et al. Among authors: wiessner c. Ann Neurol. 2002 Jun;51(6):790-3. doi: 10.1002/ana.10210. Ann Neurol. 2002. PMID: 12112090

4

Anti-Nogo-A antibody infusion 24 hours after experimental stroke improved behavioral outcome and corticospinal plasticity in normotensive and spontaneously hypertensive rats.

Wiessner C, Bareyre FM, Allegrini PR, Mir AK, Frentzel S, Zurini M, Schnell L, Oertle T, Schwab ME. Wiessner C, et al. J Cereb Blood Flow Metab. 2003 Feb;23(2):154-65. doi: 10.1097/01.WCB.0000040400.30600.AF. J Cereb Blood Flow Metab. 2003. PMID: 12571447

5

Targeting monocyte chemoattractant protein-1 signalling in disease.

Dawson J, Miltz W, Mir AK, Wiessner C. Dawson J, et al. Among authors: wiessner c. Expert Opin Ther Targets. 2003 Feb;7(1):35-48. doi: 10.1517/14728222.7.1.35. Expert Opin Ther Targets. 2003. PMID: 12556201 Review.

6

Aged APP23 mice show a delay in switching to the use of a strategy in the Barnes maze.

Prut L, Abramowski D, Krucker T, Levy CL, Roberts AJ, Staufenbiel M, Wiessner C. Prut L, et al. Among authors: wiessner c. Behav Brain Res. 2007 Apr 16;179(1):107-10. doi: 10.1016/j.bbr.2007.01.017. Epub 2007 Jan 31. Behav Brain Res. 2007. PMID: 17324476

7

Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model.

Hughes PM, Allegrini PR, Rudin M, Perry VH, Mir AK, Wiessner C. Hughes PM, et al. Among authors: wiessner c. J Cereb Blood Flow Metab. 2002 Mar;22(3):308-17. doi: 10.1097/00004647-200203000-00008. J Cereb Blood Flow Metab. 2002. PMID: 11891436

8

Characterization of two novel proteins, NgRH1 and NgRH2, structurally and biochemically homologous to the Nogo-66 receptor.

Pignot V, Hein AE, Barske C, Wiessner C, Walmsley AR, Kaupmann K, Mayeur H, Sommer B, Mir AK, Frentzel S. Pignot V, et al. Among authors: wiessner c. J Neurochem. 2003 May;85(3):717-28. doi: 10.1046/j.1471-4159.2003.01710.x. J Neurochem. 2003. PMID: 12694398 Free article.

9

Intrathecally infused antibodies against Nogo-A penetrate the CNS and downregulate the endogenous neurite growth inhibitor Nogo-A.

Weinmann O, Schnell L, Ghosh A, Montani L, Wiessner C, Wannier T, Rouiller E, Mir A, Schwab ME. Weinmann O, et al. Among authors: wiessner c. Mol Cell Neurosci. 2006 May-Jun;32(1-2):161-73. doi: 10.1016/j.mcn.2006.03.007. Epub 2006 May 11. Mol Cell Neurosci. 2006. PMID: 16697217 Free article.

10

The HSP70 molecular chaperone is not beneficial in a mouse model of alpha-synucleinopathy.

Shimshek DR, Mueller M, Wiessner C, Schweizer T, van der Putten PH. Shimshek DR, et al. Among authors: wiessner c. PLoS One. 2010 Apr 2;5(4):e10014. doi: 10.1371/journal.pone.0010014. PLoS One. 2010. PMID: 20368804 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters